Quantcast

Latest Prenatal diagnosis Stories

2011-06-23 07:00:00

PHILADELPHIA, June 23, 2011 /PRNewswire/ -- This month marks the third anniversary of the opening of The Children's Hospital of Philadelphia's (CHOP) Garbose Family Special Delivery Unit, the world's first birth facility exclusively for mothers carrying babies with known birth defects like spina bifida and congenital diaphragmatic hernia. Babies diagnosed with these birth defects will either undergo fetal surgery to treat the condition before birth or need immediate specialized care after...

2011-06-07 06:00:00

SAN DIEGO, June 7, 2011 /PRNewswire/ -- Sequenom, Inc. (NASDAQ: SQNM), a life sciences company providing innovative genetic analysis solutions, today announced the acceptance for publication of the manuscript titled, "Fetal RHD Genotype Detection from Circulating Cell-Free Fetal DNA in Maternal Plasma in Non-Sensitized RhD Negative Women." The article is currently available online and will appear in the next issue of Prenatal Diagnosis. The study, conducted by the company's wholly-owned...

2011-05-21 00:01:24

Request A Test, Ltd., a privately held business offering direct-to-consumer lab screenings in a rapid, discreet and affordable way, has just announced the addition of prenatal and thyroid testing to its list of screening services. Cleveland, Ohio (PRWEB) May 19, 2011 Request A Test, Ltd., a privately held business offering direct-to-consumer lab screenings in a rapid, discreet and affordable way, has just announced the addition of prenatal and thyroid testing to its list of screening...

2011-04-26 07:00:00

SAN CARLOS, Calif., April 26, 2011 /PRNewswire/ -- Verinata Health, Inc., (Verinata) a privately-held company dedicated to maternal and fetal health, today announced the publication of study results using its proprietary prenatal test to accurately identify multiple fetal chromosomal abnormalities from maternal blood. All trisomy 21 and trisomy 18 test samples were classified correctly. The publication, entitled 'Optimal Detection of Fetal Chromosomal Abnormalities Using Massively Parallel...

2011-04-26 07:00:00

SAN CARLOS, Calif., April 26, 2011 /PRNewswire/ -- Artemis Health, Inc., a privately-held company dedicated to maternal and fetal health, today announced that it has changed its name to Verinata Health, Inc. to better reflect its core mission of providing accurate ("veri") assessments of natal ("nata") health. Currently, Verinata Health, Inc. (Verinata) is focused on completing the clinical validation of its first non-invasive prenatal diagnostic (NIPD) test. This test is designed to...

2011-04-21 05:00:00

NEW YORK, April 21, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has secured an initial funding round of $2.5 million from four investors - three biotechnology venture capital groups and one angel investor. The round will finance a clinical trial and laboratory testing of a new, minimally invasive blood test designed to identify risks to pregnancy...

2011-04-18 13:39:00

NEW YORK, April 18, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive options agreement with Cedars-Sinai Medical Center to research a new blood test that could predict the risk of premature births early in pregnancy - or even before women become pregnant. Preterm delivery (PTD) is the leading cause of infant mortality in the world,...

2011-04-07 19:02:10

A new study demonstrates that a procedure used in preconception diagnosis to identify eggs that are free of genetic disease might not work well in all cases. The research, published by Cell Press in the April issue of the American Journal of Human Genetics, highlights the issues associated with analyzing the amount of mutant mitochondrial DNA in supporting cells as a proxy for eggs prior to in vitro fertilization. Preimplantation genetic diagnosis (PGD) and preconception diagnosis (PCD) are...

2011-04-06 10:30:00

NEW YORK, April 6, 2011 /PRNewswire/ -- KellBenx, a biotechnology company focused on the development of non-invasive prenatal diagnosis (NIPD) of genetic and inherited disorders, announced today that it has signed an exclusive agreement with AdnaGen, a wholly-owned subsidiary of Alere, Inc., to license specific antibodies. Under the agreement, KellBenx will have exclusive worldwide rights to commercialize the antibodies, which enable the extraction of clinically relevant information from...

2011-03-18 00:00:28

The Update on Prenatal Diagnosis and Treatment of Fetal Anomalies conference occurs in Philadelphia today through March 19 Philadelphia, PA (Vocus/PRWEB) March 16, 2011 An international group of over 300 medical experts gathers today to discuss the most current advances in prenatal diagnosis and treatment of birth defects. About one in every 33 babies born each year in the United States has some type of major birth defect. Birth defects are also the leading cause of infant death. The...


Word of the Day
attercop
  • A spider.
  • Figuratively, a peevish, testy, ill-natured person.
'Attercop' comes from the Old English 'atorcoppe,' where 'atter' means 'poison, venom' and‎ 'cop' means 'spider.' 'Coppa' is a derivative of 'cop,' top, summit, round head, or 'copp,' cup, vessel, which refers to 'the supposed venomous properties of spiders,' says the OED. 'Copp' is still found in the word 'cobweb.'
Related